TRIUMF

    OverviewSuggest Edit

    TRIUMF is a national laboratory for particle and nuclear physics and accelerator-based science. It is pushing the frontiers in isotope science and innovation, as well as technologies to address fundamental and applied problems in particle and nuclear physics, and the materials and life sciences.
    TypePrivate
    Founded1968
    HQVancouver, CA
    Websitetriumf.ca
    Employee Ratings4.1

    Latest Updates

    Employees (est.) (Nov 2021)505
    Cybersecurity ratingDMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at TRIUMF

    Jonathan Bagger

    Jonathan Bagger

    Director
    Reiner Kruecken

    Reiner Kruecken

    Deputy Director, Research
    Anne Louise Aboud

    Anne Louise Aboud

    Chief Operating Officer, Deputy Director, Operations
    Oliver Kester

    Oliver Kester

    Associate Lab Director, Accelerator Division
    Paul Schaffer

    Paul Schaffer

    Associate Lab Director, Life Sciences Division
    Jens Dilling

    Jens Dilling

    Associate Lab Director, Physical Sciences Division
    Show more

    TRIUMF Office Locations

    TRIUMF has an office in Vancouver
    Vancouver, CA (HQ)
    4004 Wesbrook Mall
    Vancouver, CA
    4004 Wesbrook Mall
    Show all (2)

    TRIUMF Financials and Metrics

    Summary Metrics

    Founding Date

    1968

    TRIUMF Cybersecurity Score

    Cybersecurity ratingPremium dataset

    D

    64/100

    SecurityScorecard logo

    TRIUMF Online and Social Media Presence

    Embed Graph

    TRIUMF News and Updates

    TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a Cancer-Fighting Medical Isotope

    VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) -- TRIUMF, Canada’s particle accelerator centre, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiop…

    TRIUMF Blogs

    IRIS provides a glimpse of deformation in helium-8

    16 November 2021 (image: Rituparna Kanungo, Principal Investigator, and Petr Navratil (TRIUMF Theory lead, with the IRIS spectroscopy station in TRIUMF’s ISAC-II facility) New TRIUMF research from the Saint Mary’s University-led IRIS group has unveiled an unexpected shape deformation in the…

    E-linac teams hit 2021 commissioning target ahead of schedule

    13 October 2021 On Monday, September 13th, teams working on TRIUMF’s Advanced Rare Isotope Laboratory (ARIEL) achieved a major milestone for the facility’s electron linear accelerator (e-linac) by reaching an average beam power of 10 kW at the e-linac's design energy of 30 MeV. The results, …

    TRIUMF and Fusion Pharmaceuticals announce expanded R&D collaboration for Actinium Supply Production

    12 August 2021 TRIUMF and Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, have entered into the next phase of their collaboration agreement for the development, production, and supply of actiniu…

    Dr. Jens Dilling to become Director of Institutional Strategic Planning at ORNL

    02 July 2021 After 20 years of service to TRIUMF, including nearly six years as the Associate Lab Director (ALD) - Physical Sciences Division, Jens Dilling will be departing the laboratory on July 31, 2021 to take on a new challenge as the Director of Institutional Strategic Planning at Oak …

    TRIUMF joins RADNEXT infrastructure network

    21 June 2021 TRIUMF has joined RADNEXT (‘RADiation facility Network for the EXploration of effects for indusTry and research’), a five million euro Horizons 2020 infrastructure project that will fund different work packages and establish a global network of facilities and related irradiation…

    Dr. Tom Ruth Awarded SNMMI’s 2021 George Charles de Hevesy Nuclear Pioneer Award

    14 June 2021 TRIUMF Emeritus Senior Scientist Dr. Tom Ruth has been awarded the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 George Charles de Hevesy Nuclear Pioneer Award. The announcement was made on Sunday, June 13 as part of the SNMMI 2021 Virtual Annual Meeting.   Hon…
    Show more

    TRIUMF Frequently Asked Questions

    • When was TRIUMF founded?

      TRIUMF was founded in 1968.

    • Who are TRIUMF key executives?

      TRIUMF's key executives are Jonathan Bagger, Reiner Kruecken and Anne Louise Aboud.

    • How many employees does TRIUMF have?

      TRIUMF has 505 employees.

    • Who are TRIUMF competitors?

      Competitors of TRIUMF include Fermilab, Klick and Eltel.

    • Where is TRIUMF headquarters?

      TRIUMF headquarters is located at 4004 Wesbrook Mall, Vancouver.

    • Where are TRIUMF offices?

      TRIUMF has an office in Vancouver.

    • How many offices does TRIUMF have?

      TRIUMF has 2 offices.